Cyteir Therapeutics, Inc.
CYTDelisted Mar 18, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001662244
Cyteir Therapeutics, Inc. was delisted on Mar 18, 2024; its insiders filed their last Form 4 on Mar 25, 2024; 38 institutions reported holding it in 13F filings for Q4 2023, worth $38.9M in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 38
- Q4 2023, −2 vs. previous quarter
- 13F value
- $38.9M
- Reported value at the end of Q4 2023
- Superinvestors holding
- 0
- At the end of Q4 2023
Superinvestors holding CYT, Q4 2023
No superinvestor reported holding CYT at the end of Q4 2023.
Latest insider trades
Open-market purchases and sales by Cyteir Therapeutics, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 25, 2024 (view filing) | Mar 20 | 5 daysLate | Leonard Braden Michael10% Owner | PPurchaseCommon Stock, par value $0.001 per share | +170.6K | $2.95 | +$503.2K | +4.9%3.65M after | |
| Mar 19, 2024 (view filing) | Mar 18 | 1 day | Leonard Braden Michael10% Owner | PPurchaseCommon Stock, par value $0.001 per share | +113.8K | $3.01 | +$342.5K | +3.4%3.48M after | |
| Jul 20, 2023 (view filing) | Jul 19-20 | 1 day | Novo Holdings A/S10% Owner | SSale | −101.9K | $2.75 | −$280.2K | −2.8%3.52M after | 2 lots |
| Jul 18, 2023 (view filing) | Jul 14-18 | 4 days | Novo Holdings A/S10% Owner | SSale | −38.6K | $2.75 | −$106.1K | −1.1%3.62M after | 3 lots |
| Jul 3, 2023 (view filing) | Jun 30 | 3 days | Novo Holdings A/S10% Owner | SSale | −200.9K | $2.63 | −$528.5K | −5.2%3.66M after | |
| Jun 28, 2023 (view filing) | Jun 26-27 | 2 days | Novo Holdings A/S10% Owner | SSale | −40.4K | $1.77 | −$71.7K | −1.0%3.86M after | 2 lots |
| Jun 23, 2023 (view filing) | Jun 21-23 | 2 days | Novo Holdings A/S10% Owner | SSale | −13.3K | $1.94 | −$25.8K | −0.3%3.90M after | 3 lots |
| Jun 20, 2023 (view filing) | Jun 15-20 | 5 days | Novo Holdings A/S10% Owner | SSale | −16.7K | $2.03 | −$34.0K | −0.4%3.92M after | 3 lots |
| Jun 14, 2023 (view filing) | Jun 12-14 | 2 days | Novo Holdings A/S10% Owner | SSale | −6.40K | $2.10 | −$13.4K | −0.2%3.93M after | 3 lots |
| Dec 8, 2022 (view filing) | Dec 7 | 1 day | Zakrzewski Joseph SDirector | PPurchase | +21.2K | $1.30 | +$27.6K | +15.9%154.6K after | From original |
Top 10 13F holders, Q4 2023
The largest institutional positions in Cyteir Therapeutics, Inc. at the end of Q4 2023; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BML Capital Management, LLC | 3,250,008 | $9.88M | 7.80% | 00.0% | Unchanged |
| Newtyn Management, LLC | 3,021,500 | $9.19M | 1.80% | +521,056+20.8% | Added |
| Gabelli Funds LLC | 1,110,050 | $3.37M | 0.03% | +667,412+150.8% | Added |
| Anson Funds Management LP | 1,096,422 | $3.33M | 0.69% | −227,692−17.2% | Reduced |
| Gabelli & Co Investment Advisers, Inc. | 1,026,000 | $3.12M | 0.59% | +609,800+146.5% | Added |
| Vanguard Group Inc | 687,391 | $2.09M | 0.00% | +46,611+7.3% | Added |
| Millennium Management LLC | 451,980 | $1.37M | 0.00% | +451,980 | New |
| Walleye Capital LLC | 427,037 | $1.30M | 0.02% | +73,121+20.7% | Added |
| Laurion Capital Management LP | 316,201 | $961.3K | 0.03% | −43,299−12.0% | Reduced |
| Bulldog Investors, LLP | 200,000 | $608.0K | 0.20% | 00.0% | Unchanged |